GCTK

0.82% -0.006

Handel nachbörslich: .71 -0.02 -2.74%

Glucotrack Inc (GCTK)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Glucotrack Inc Stock (GCTK) Company Profile

Glucotrack Inc

Healthcare (1106)

972 (8) 675-7878

301 RT 17 NORTH, RUTHERFORD

Nächster Verdiensttermin

Neueste SEC-Einreichungen

GCTK's Discussions on Twitter

Compare GCTK vs ISRG, BDX, MDLN, ALC, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GCTK Glucotrack Inc	0.73	2.69M	0	-19.39M	-15.34M	-18.91
ISRG Intuitive Surgical Inc	451.38	160.21B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	144.17	41.62B	21.92B	1.76B	2.63B	6.1223
MDLN Medline Inc	45.32	37.37B	28.43B	1.16B	1.26B	1.4457
ALC Alcon Inc	74.45	35.82B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	207.88	30.38B	5.40B	1.49B	1.78B	10.12

Glucotrack Inc Aktie (GCTK) Neueste Nachrichten

Finanzdaten der Glucotrack Inc-Aktie (GCTK)

Glucotrack Inc (GCTK)

Glucotrack Inc Stock (GCTK) Company Profile

Compare GCTK vs ISRG, BDX, MDLN, ALC, RMD

Glucotrack Inc Aktie (GCTK) Neueste Nachrichten

GlucoTrack Executes Debt-for-Equity Exchange and Investor Update - The Globe and Mail

Peer-Reviewed Study in Journal of Diabetes Research Verifies Glucotrack’s Long‑Term Continuous Blood Glucose Monitoring Technology - citybiz

[EFFECT] Glucotrack, Inc. SEC Filing - Stock Titan

Glucotrack (NASDAQ: GCTK) swaps $988K debt for 1.3M new shares - Stock Titan

GlucoTrack Reports Strong Preclinical Data for Implantable CBGM - TipRanks

Peer-reviewed CBGM data back Glucotrack (NASDAQ: GCTK) IDE plans - Stock Titan

Glucotrack publishes 240-day glucose monitor study results - Investing.com

Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology - The Manila Times

An implantable glucose monitor held accuracy for 240 days in animal study - Stock Titan

Glucotrack, Inc. (NASDAQ: GCTK) registers 20.06M shares tied to $20M financing - Stock Titan

GCTK Stock Chops Higher As GlucoTrack Marks Key CGM Milestones - StocksToTrade

GCTK Stock Pops As GlucoTrack Marks Key CGM Milestones - timothysykes.com

GlucoTrack stock gains as data backs FDA filing plans for glucose monitoring tech - MSN

GCTK stock is soaring pre-market today — what is fueling the surge? - MSN

GCTK Stock Price, Quote & Chart | GLUCOTRACK INC (NASDAQ:GCTK) - ChartMill

GlucoTrack Stock Short Interest Falls to 73.9% - Quiver Quantitative

GlucoTrack files to sell 20.06M shares of common stock by selling shareholders - MSN

GCTK GlucoTrack lays out new commercial growth plans in its latest quarterly earnings release for non-invasive glucose monitors.Dividend Report - Cổng thông tin điện tử tỉnh Tây Ninh

Study Supports GlucoTrack’s Blood Glucose Monitoring Implant - Yahoo Finance

GlucoTrack announces publication of peer-reviewed article on glucose sensors - TipRanks

New Peer-Reviewed Study Supports Glucotrack’s Long-Duration Implantable Continuous Blood Glucose Monitoring Technology - citybiz

Glucotrack publishes peer-reviewed study on glucose sensor stability - Investing.com

Glucotrack publishes peer-reviewed study on glucose sensor stability By Investing.com - Investing.com Canada

Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology - marketscreener.com

One-year lab test backs Glucotrack implantable glucose monitor - Stock Titan

GlucoTrack (GCTK) Stock Investment Today (Volatility Increases) 2026-04-20Turnaround Stocks - Cổng thông tin điện tử tỉnh Lào Cai

GCTK | GlucoTrack, Inc. Common Stock Insider Trading - Quiver Quantitative

GlucoTrack (GCTK) Stock Volume Drop (Smart Money Active) 2026-04-18Shared Buy Zones - Newser

Should You Hold GlucoTrack (GCTK) Stock? (Technical Weakness) 2026-04-16Momentum Signals - Cổng thông tin điện tử tỉnh Lào Cai

GlucoTrack Executes Debt-for-Equity Exchange to Reduce Obligations - The Globe and Mail

Glucotrack exchanges $600,000 note for 895,000 shares with investor By Investing.com - Investing.com

Glucotrack Swaps $600,000 Note Portion for 895,000 Shares Under Exchange Agreement - TradingView

Glucotrack (NASDAQ: GCTK) swaps $600K debt for 895,000 shares - Stock Titan

Technical Analysis: Is GlucoTrack Inc impacted by rising ratesProduct Launch & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn

$Glucotrack (GCTK.US)$ thanks market - Moomoo

RSI Check: Will GlucoTrack Inc benefit from geopolitical trends2026 Intraday Action & Weekly High Return Stock Forecasts - baoquankhu1.vn

Glucotrack reports net loss of USD 19.4M in FY 2025 - Medical Buyer

Glucotrack, Inc. 2025 Annual Report – Implantable Continuous Blood Glucose Monitor Development, Regulatory Progress, and Risk Factors 66 - Minichart

GCTK: Improved net loss and cash position support 2026 clinical trial launch for implantable CBGM - TradingView — Track All Markets

Glucotrack (GCTK) advances implantable CBGM but flags going concern risk - Stock Titan

GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Glucotrack (NASDAQ: GCTK) trims 2025 loss and readies IDE for implantable CBGM trials - Stock Titan

Glucotrack, Inc. Announces IDE Filing Plans for Continuous Blood Glucose Monitoring Technology and Patents Issued by USPTO - Quiver Quantitative

Glucotrack’s 3-year glucose implant targets a U.S. human trial in 2026 - Stock Titan

Technical Analysis: What analysts say about GlucoTrack Inc stock2026 Analyst Calls & Low Drawdown Trading Techniques - baoquankhu1.vn

GlucoTrack Plummets 27%: Is This the Bottom of a Deep Downtrend? A High-Stakes Analysis for 2026 - Bitget

GCTK PE Ratio & Valuation, Is GCTK Overvalued - Intellectia AI

GlucoTrack, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Finanzdaten der Glucotrack Inc-Aktie (GCTK)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie GCTK